|
Volumn 30, Issue 3, 2008, Pages 221-224
|
Efficacy and safety of gefitinib in maintenance therapy for patients with advanced non-small cell lung cancer
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
GEFITINIB;
QUINAZOLINE DERIVATIVE;
ARTICLE;
CANCER STAGING;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
DIARRHEA;
DISEASE FREE SURVIVAL;
FEMALE;
HUMAN;
LIVER TUMOR;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
MALE;
METASTASIS;
MIDDLE AGED;
PATHOLOGY;
PROPORTIONAL HAZARDS MODEL;
RASH;
REMISSION;
SMOKING;
SURVIVAL RATE;
TUMOR RECURRENCE;
ANTINEOPLASTIC AGENTS;
CARCINOMA, NON-SMALL-CELL LUNG;
DIARRHEA;
DISEASE-FREE SURVIVAL;
EXANTHEMA;
FEMALE;
HUMANS;
LIVER NEOPLASMS;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM STAGING;
PROPORTIONAL HAZARDS MODELS;
QUINAZOLINES;
REMISSION INDUCTION;
SMOKING;
SURVIVAL RATE;
|
EID: 66749097179
PISSN: 02533766
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (7)
|
References (0)
|